Hu Y, Han L, Xu W, Li T, Zhao Q, Lu W
Front Immunol. 2024; 15:1364957.
PMID: 38650932
PMC: 11033321.
DOI: 10.3389/fimmu.2024.1364957.
Steinmetz T, Thomas J, Reimann L, Himmelreich A, Schulz S, Golombek F
J Proteome Res. 2024; 23(5):1615-1633.
PMID: 38649144
PMC: 11077586.
DOI: 10.1021/acs.jproteome.3c00713.
Chmiest D, Podavini S, Ioannidou K, Vallois D, Decaillet C, Gonzalez M
Blood Adv. 2024; 8(11):2908-2923.
PMID: 38513140
PMC: 11176957.
DOI: 10.1182/bloodadvances.2023011901.
Liu X, Zhang G, Li S, Liu Y, Ma K, Wang L
Aging (Albany NY). 2024; 16(3):2249-2272.
PMID: 38289597
PMC: 10911361.
DOI: 10.18632/aging.205480.
Alsaidalani A, Garcia-Solis B, Bukhari E, Van Den Rym A, Lopez-Collazo E, Sanchez-Ramon S
J Clin Immunol. 2023; 44(1):13.
PMID: 38129623
PMC: 10966939.
DOI: 10.1007/s10875-023-01619-z.
Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets.
Laletin V, Bernard P, Da Silva C, Guittard G, Nunes J
J Immunother Cancer. 2023; 11(5).
PMID: 37217244
PMC: 10231026.
DOI: 10.1136/jitc-2022-005845.
MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.
Minderman M, Lantermans H, Gruneberg L, Cillessen S, Bende R, van Noesel C
Blood Cancer J. 2023; 13(1):37.
PMID: 36922488
PMC: 10017792.
DOI: 10.1038/s41408-023-00809-7.
NFκB signaling in T cell memory.
Daniels M, Luera D, Teixeiro E
Front Immunol. 2023; 14:1129191.
PMID: 36911729
PMC: 9998984.
DOI: 10.3389/fimmu.2023.1129191.
Bioinformatics Analysis of miRNAs Targeting TRAF5 in DLBCL Involving in NF-B Signaling Pathway and Affecting the Apoptosis and Signal Transduction.
Li C, Huang L, Wen Y, Yi M, Gao M
Genet Res (Camb). 2023; 2022:3222253.
PMID: 36619898
PMC: 9803564.
DOI: 10.1155/2022/3222253.
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.
Levy R, Gothe F, Momenilandi M, Magg T, Materna M, Peters P
J Exp Med. 2022; 220(2).
PMID: 36515678
PMC: 9754768.
DOI: 10.1084/jem.20220275.
Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience.
Urdinez L, Erra L, Palma A, Mercogliano M, Fernandez J, Prieto E
Front Immunol. 2022; 13:1020927.
PMID: 36405754
PMC: 9668901.
DOI: 10.3389/fimmu.2022.1020927.
A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review.
Zhao P, Hu Y, Sun D, Meng Q, Zhang L, Zhang X
Front Immunol. 2022; 13:943027.
PMID: 36203613
PMC: 9530255.
DOI: 10.3389/fimmu.2022.943027.
Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma.
Liu X, Ning J, Liu X, Chan W
Cancers (Basel). 2022; 14(15).
PMID: 35954378
PMC: 9367541.
DOI: 10.3390/cancers14153716.
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.
Xia M, David L, Teater M, Gutierrez J, Wang X, Meydan C
Cancer Discov. 2022; 12(8):1922-1941.
PMID: 35658124
PMC: 9357155.
DOI: 10.1158/2159-8290.CD-21-1566.
CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain.
Cho J, Yoon S, Kim S, Ko Y, Kim W
Blood Adv. 2022; 6(24):6120-6130.
PMID: 35475881
PMC: 9768246.
DOI: 10.1182/bloodadvances.2021006305.
Methylation of Immune-Related Genes in Peripheral Blood Leukocytes and Breast Cancer.
Tian T, Fu J, Li D, Liu Y, Sun H, Wang X
Front Oncol. 2022; 12:817565.
PMID: 35223499
PMC: 8867609.
DOI: 10.3389/fonc.2022.817565.
CARD9 Forms an Alternative CBM Complex in Richter Syndrome.
Maier J, Lechel A, Marienfeld R, Barth T, Moller P, Mellert K
Cancers (Basel). 2022; 14(3).
PMID: 35158799
PMC: 8833648.
DOI: 10.3390/cancers14030531.
Small Molecule Inhibitors Targeting Nuclear Factor κB Activation Markedly Reduce Expression of Interleukin-2, but Not Interferon-γ, Induced by Phorbol Esters and Calcium Ionophores.
Tanaka Y, Nakao A, Miyake Y, Higashi Y, Tanigaki R, Kataoka T
Int J Mol Sci. 2021; 22(23).
PMID: 34884902
PMC: 8658103.
DOI: 10.3390/ijms222313098.
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling.
Kuo S, Yang S, Wei M, Lee H, Tien Y, Cheng A
Cancer Cell Int. 2021; 21(1):436.
PMID: 34412631
PMC: 8375138.
DOI: 10.1186/s12935-021-02143-z.
The Multiple Roles of the Cytosolic Adapter Proteins ADAP, SKAP1 and SKAP2 for TCR/CD3 -Mediated Signaling Events.
Dadwal N, Mix C, Reinhold A, Witte A, Freund C, Schraven B
Front Immunol. 2021; 12:703534.
PMID: 34295339
PMC: 8290198.
DOI: 10.3389/fimmu.2021.703534.